Moolec Science SA (MLEC)
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA Summary
Moolec Has Received USDA Approval for the First Genetically Modified Pea in History
LUXEMBOURG / ACCESSWIRE / October 16, 2024 / Moolec Science SA (NASDAQ:MLEC) ("the Company"), a leader in Molecular Farming technology, announced today that the U.S. Department of Agriculture's ("USDA") Animal and Plant Health Inspection Service ("APHIS") has completed its Regulatory Status Review ("RSR") for the Company's genetically engineered ("GE") peas which produce iron through bovine meat proteins. This is the third regulatory clearance from USDA-APHIS achieved by Moolec in an 18-month window, alongside its genetically engineered safflower and soybean for GLASO™ and Piggy Sooy™ products, respectively.
Moolec Science (MLEC) Q4 2024 Earnings Call Transcript
Moolec Science SA (NASDAQ:MLEC ) Q4 2024 Earnings Conference Call October 2, 2024 8:30 AM ET Company Participants Gaston Paladini - Chief Executive Officer Jose Lopez Lecube - Chief Financial Officer Martin Salinas - Chief Technology Officer Amit Dhingra - Chief Science Officer Bill Zima - ICR Strategic Communications Conference Call Participants Scott Fortune - Roth Capital Operator Good morning and welcome to Moolec Science's fourth quarter and full fiscal year 2024 conference call. My name is Bill Zima of ICR Strategic Communications and Advisory.
Moolec Science Presents Fiscal Year 2024 Annual Business Update
LUXEMBOURG / ACCESSWIRE / October 2, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today reported its Business Update for the fourth quarter of Fiscal Year 2024 ended June 30, 2024. Moolec Science Logo The main highlights of Moolec's fourth quarter are as follows: GLASO™: The Company announced an offtake agreement with a major global CPG food and pet food company and an R&D collaboration agreement with Bunge.
Moolec Science SA (MLEC) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Moolec Science SA ever had a stock split?
Moolec Science SA Profile
| Biotechnology Industry | Healthcare Sector | Alejandro Antalich CEO | NASDAQ (CM) Exchange | L64875120 CUSIP |
| LU Country | 52 Employees | - Last Dividend | 5 Jan 2026 Last Split | 3 Jan 2023 IPO Date |
Overview
Moolec Science SA is a pioneering food ingredient company with a firm foundation in science, primarily focused on the integration of real animal proteins within plant hosts through the innovative approach of molecular farming. Initiated in 2020 and headquartered in Luxembourg, Moolec Science has expanded its operational reach, encompassing the United States, Europe, and South America. This strategic expansion is driven by the company's commitment to revolutionizing the food industry by offering sustainable, plant-based alternatives that do not compromise on the nutritional value and sensory experience of animal-derived ingredients.
Products and Services
-
Chymosin SPC:
A dairy ingredient designed to cater to the cheese-making industry, Chymosin SPC leverages the precision of molecular farming to replicate crucial cheesemaking enzymes directly within plants, offering a sustainable and animal-free alternative to traditional sources.
-
GLA SONOVA:
A premium nutritional oil enriched with Gamma-Linolenic Acid (GLA), GLA SONOVA targets the health and wellness sector by providing a critical fatty acid through a plant-based medium, which is pivotal for maintaining heart health, hormonal balance, and skin vitality.
-
POORK+:
This innovative product navigates the intersection between plant-based ingredients and animal proteins by introducing porcine proteins into soybeans, creating a groundbreaking plant-based, pork alternative. POORK+ aims to satisfy the growing consumer demand for meat-free options without compromising the taste and nutritional profile found in traditional pork products.
-
BEEF+:
As a meat replacement product, BEEF+ stands at the forefront of the plant-based revolution, introducing real beef proteins into plant matrices. This product endeavors to redefine meat consumption by offering a sustainable, ethical, and nutritionally equivalent alternative to conventional beef, catering to both the culinary preferences and environmental concerns of modern consumers.
